Home » Medtronic Study for PAD Patients
Medtronic Study for PAD Patients
Medtronic announced the initiation of IN.PACT SFA II study to evaluate the safety and efficacy of its Admiral drug-eluting balloon in the treatment of peripheral artery disease in the superficial femoral artery and/or proximal popliteal artery.
Daily Markets
Daily Markets
Upcoming Events
-
07May
-
14May
-
30May